tradingkey.logo
tradingkey.logo
Buscar

SI-BONE Inc

SIBN
Añadir a la lista de seguimiento
17.110USD
+0.310+1.85%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
758.82MCap. mercado
PérdidaP/E TTM

Más Datos de SI-BONE Inc Compañía

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Información de SI-BONE Inc

Símbolo de cotizaciónSIBN
Nombre de la empresaSI-BONE Inc
Fecha de salida a bolsaOct 17, 2018
Director ejecutivoFrancis (Laura A)
Número de empleados349
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 17
Dirección471 El Camino Real, Suite 101
CiudadSANTA CLARA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal95050
Teléfono14082070700
Sitio Webhttps://si-bone.com/
Símbolo de cotizaciónSIBN
Fecha de salida a bolsaOct 17, 2018
Director ejecutivoFrancis (Laura A)

Ejecutivos de SI-BONE Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
172.06K
+1.79%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
87.64K
+8.42%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
58.24K
-8.01%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
35.10K
+31.22%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
35.00K
+31.31%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
20.11K
+54.47%
Ms. Laura A. Francis
Ms. Laura A. Francis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Michael A. Pisetsky
Mr. Michael A. Pisetsky
Secretary, Chief Business & Legal Affairs Officer
Secretary, Chief Business & Legal Affairs Officer
--
--
Mr. Anthony J. Recupero, Ph.D.
Mr. Anthony J. Recupero, Ph.D.
President - Commercial Operations
President - Commercial Operations
--
--
Mr. Timothy E. (Ted) Davis, Jr.
Mr. Timothy E. (Ted) Davis, Jr.
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
172.06K
+1.79%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
87.64K
+8.42%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
58.24K
-8.01%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
35.10K
+31.22%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
35.00K
+31.31%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
20.11K
+54.47%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de SI-BONE Inc?

Los cinco principales accionistas de SI-BONE Inc son: Mr. Gregory K. (Greg) Hinckley, CPA

¿Cuántas instituciones poseen acciones de SI-BONE Inc (SIBN)?

A fecha de 2026Q1, 367 instituciones poseen acciones de SI-BONE Inc, con un valor de mercado combinado de aproximadamente 45.75M, lo que representa el 103.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2298649.00.